IMM-363

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIMM-363
Drug Alias Nameantibody-rich colostrum (Immuron)IMM-363
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyNatural product/Extract
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRadiation sickness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmuron Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmuron Ltd
Active IndicationsN/A
Inactive IndicationsRadiation sickness

Other Information

ATC CodeN/A
Related LinksN/A